Loading...

Cosmos Health Inc.

COSMNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.38
$0.02(6.39%)
U.S. Market opens in NaNh NaNm

Cosmos Health Inc. Fundamental Analysis

Cosmos Health Inc. (COSM) shows weak financial fundamentals with a PE ratio of -0.59, profit margin of -29.33%, and ROE of -81.69%. The company generates $0.1B in annual revenue with weak year-over-year growth of 1.97%.

Key Strengths

PEG Ratio-0.01

Areas of Concern

ROE-81.69%
Operating Margin-25.34%
We analyze COSM's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -83.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-83.1/100

We analyze COSM's fundamental strength across five key dimensions:

Efficiency Score

Weak

COSM struggles to generate sufficient returns from assets.

ROA > 10%
-29.24%

Valuation Score

Excellent

COSM trades at attractive valuation levels.

PE < 25
-0.59
PEG Ratio < 2
-0.01

Growth Score

Moderate

COSM shows steady but slowing expansion.

Revenue Growth > 5%
1.97%
EPS Growth > 10%
45.58%

Financial Health Score

Excellent

COSM maintains a strong and stable balance sheet.

Debt/Equity < 1
0.59
Current Ratio > 1
1.00

Profitability Score

Weak

COSM struggles to sustain strong margins.

ROE > 15%
-8169.15%
Net Margin ≥ 15%
-29.33%
Positive Free Cash Flow
No

Key Financial Metrics

Is COSM Expensive or Cheap?

P/E Ratio

COSM trades at -0.59 times earnings. This suggests potential undervaluation.

-0.59

PEG Ratio

When adjusting for growth, COSM's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Cosmos Health Inc. at 0.62 times its book value. This may indicate undervaluation.

0.62

EV/EBITDA

Enterprise value stands at -0.08 times EBITDA. This is generally considered low.

-0.08

How Well Does COSM Make Money?

Net Profit Margin

For every $100 in sales, Cosmos Health Inc. keeps $-29.33 as profit after all expenses.

-29.33%

Operating Margin

Core operations generate -25.34 in profit for every $100 in revenue, before interest and taxes.

-25.34%

ROE

Management delivers $-81.69 in profit for every $100 of shareholder equity.

-81.69%

ROA

Cosmos Health Inc. generates $-29.24 in profit for every $100 in assets, demonstrating efficient asset deployment.

-29.24%

Following the Money - Real Cash Generation

Operating Cash Flow

Cosmos Health Inc. generates limited operating cash flow of $-9.96M, signaling weaker underlying cash strength.

$-9.96M

Free Cash Flow

Cosmos Health Inc. generates weak or negative free cash flow of $-10.21M, restricting financial flexibility.

$-10.21M

FCF Per Share

Each share generates $-0.34 in free cash annually.

$-0.34

FCF Yield

COSM converts -90.06% of its market value into free cash.

-90.06%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.59

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.62

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.17

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.59

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.003

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.82

vs 25 benchmark

ROA

Return on assets percentage

-0.29

vs 25 benchmark

ROCE

Return on capital employed

-0.61

vs 25 benchmark

How COSM Stacks Against Its Sector Peers

MetricCOSM ValueSector AveragePerformance
P/E Ratio-0.5928.81 Better (Cheaper)
ROE-81.69%643.00% Weak
Net Margin-29.33%-44312.00% (disorted) Weak
Debt/Equity0.590.36 Weak (High Leverage)
Current Ratio1.004.50 Neutral
ROA-29.24%-17799.00% (disorted) Weak

COSM outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Cosmos Health Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-96.20%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

86.40%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

95.53%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ